trifluperidol has been researched along with trifluoperazine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (81.25) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiechtner, B; Glossmann, H; Hoffmann, RD; Laggner, C; Langer, T; Moebius, FF; Poles, G; Schieferer, C | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Løvstad, RA | 1 |
| Martin, IC | 1 |
| Kassay, G; Máthé, V; Tüske, M | 1 |
| Avrutskii, GIa; Gurovich, IIa; Prokhorova, IS; Romanov, IuD; Tirkel'taub, IuA | 1 |
| Janecek, J; Schiele, BC; Zimmermann, R | 1 |
| Menon, MS; Ramachandran, V | 1 |
| Campbell, M; Fish, B; Floyd, A; Shapiro, T | 1 |
| Bishop, MP; Gallant, DM; Nesselhof, WM; Sprehe, DJ | 1 |
| Hrychuk, W; Marjerrison, G; Varsanyi, EI | 1 |
| Campbell, M; Fish, B; Shapiro, T; Wile, R | 1 |
| Bordeleau, JM; Filotto, J; Tetreault, L | 1 |
| Crumb, WJ; Murawsky, MK; Rampe, D; Wible, B | 1 |
| BISHOP, MP; GALLANT, DM | 2 |
6 trial(s) available for trifluperidol and trifluoperazine
| Article | Year |
|---|---|
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Schizophrenia; Thioridazine; Trifluoperazine; Trifluperidol | 1975 |
A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients.
Topics: Adolescent; Adult; Antidepressive Agents; Butyrophenones; Clinical Trials as Topic; Humans; Middle Aged; MMPI; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Trifluoperazine; Trifluperidol | 1969 |
A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients.
Topics: Adult; Analysis of Variance; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Time Factors; Trifluoperazine; Trifluperidol | 1972 |
Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.
Topics: Child, Preschool; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Schizophrenia; Tranquilizing Agents; Trifluoperazine; Trifluperidol | 1969 |
Further observations on trifluperidol: a butyrophenone derivative.
Topics: Butyrophenones; Clinical Trials as Topic; Humans; Hypnotics and Sedatives; Phenobarbital; Psychological Tests; Schizophrenia; Trifluoperazine; Trifluperidol | 1965 |
A comparison of two butyrophenones with trifluoperazine.
Topics: Adult; Aged; Butyrophenones; Clinical Trials as Topic; Humans; Hypnotics and Sedatives; Middle Aged; Psychological Tests; Schizophrenia; Tranquilizing Agents; Trifluoperazine; Trifluperidol | 1966 |
10 other study(ies) available for trifluperidol and trifluoperazine
| Article | Year |
|---|---|
Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
Topics: Animals; Carrier Proteins; Databases, Factual; Guinea Pigs; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Isomerism; Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptors, sigma; Saccharomyces cerevisiae; Sigma-1 Receptor; Steroid Isomerases | 2005 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effect of centrally active drugs on dopamine oxidation by rat brain catecholamine oxidase.
Topics: Animals; Antipsychotic Agents; Brain; Chlorpromazine; Desipramine; Dopamine; Dopamine beta-Hydroxylase; Female; Haloperidol; Imipramine; Kinetics; Promazine; Rats; Thioridazine; Trifluoperazine; Trifluperidol | 1979 |
[Results of glucose tolerance tests and changes in inorganic serum phosphate and potassium levels in schizophrenic patients responding to treatment with psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Chlorpromazine; Diazepam; Glucose Tolerance Test; Haloperidol; Humans; Imipramine; Male; Methotrimeprazine; Middle Aged; Phenothiazines; Phosphates; Photometry; Potassium; Schizophrenia; Time Factors; Trifluoperazine; Trifluperidol | 1971 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorpromazine; Electroencephalography; Epinephrine; Female; Fluphenazine; Galvanic Skin Response; Haloperidol; Humans; Imipramine; Male; Middle Aged; Muscle Tonus; Perphenazine; Phenothiazines; Physical Exertion; Schizophrenia; Schizophrenia, Paranoid; Serotonin; Substance Withdrawal Syndrome; Syndrome; Tranquilizing Agents; Trifluoperazine; Trifluperidol | 1974 |
A classification of schizophrenic children under five years.
Topics: Aggression; Child, Institutionalized; Child, Preschool; Education, Special; Female; Follow-Up Studies; Hospitals, Psychiatric; Humans; Intellectual Disability; Intelligence; Language Development; Male; Mental Disorders; Motor Skills; Prognosis; Psychotic Disorders; Schizophrenia, Childhood; Speech; Trifluoperazine; Trifluperidol; Vocabulary | 1968 |
[Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
Topics: Antidepressive Agents; Butyrophenones; Chlorpromazine; Extrapyramidal Tracts; Female; Fluorine; Humans; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Tranquilizing Agents; Trifluoperazine; Trifluperidol | 1968 |
Stable expression and characterization of the human brain potassium channel Kv2.1: blockade by antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Cloning, Molecular; Female; Fluspirilene; Gene Expression; Glioblastoma; Humans; Ion Channel Gating; Molecular Sequence Data; Myocardium; Oocytes; Patch-Clamp Techniques; Pimozide; Polymerase Chain Reaction; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; RNA, Messenger; Trifluoperazine; Trifluperidol; Tumor Cells, Cultured; Xenopus | 1997 |
TRIFLUPERIDOL IN "PARANOID" AND "NON-PARANOID" SCHIZOPHRENICS.
Topics: Antidepressive Agents; Biomedical Research; Chlorpromazine; Drug Therapy; Humans; Schizophrenia; Trifluoperazine; Trifluperidol | 1965 |
SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
Topics: Antidepressive Agents; Biomedical Research; Chlorpromazine; Chlorprothixene; Drug Therapy; Extrapyramidal Tracts; Humans; Mental Disorders; Movement Disorders; Phenothiazines; Placebos; Psychopharmacology; Schizophrenia; Statistics as Topic; Toxicology; Tranquilizing Agents; Trifluoperazine; Trifluperidol | 1965 |